0001493152-24-020784.txt : 20240520 0001493152-24-020784.hdr.sgml : 20240520 20240520172711 ACCESSION NUMBER: 0001493152-24-020784 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240520 DATE AS OF CHANGE: 20240520 EFFECTIVENESS DATE: 20240520 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Immix Biopharma, Inc. CENTRAL INDEX KEY: 0001873835 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 454869378 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-513789 FILM NUMBER: 24965976 BUSINESS ADDRESS: STREET 1: 11400 WEST OLYMPIC BLVD. STREET 2: SUITE 200 CITY: LOS ANGELES STATE: CA ZIP: 90064 BUSINESS PHONE: (888) 958-1084 MAIL ADDRESS: STREET 1: 10573 W. PICO BLVD. STREET 2: #58 CITY: LOS ANGELES STATE: CA ZIP: 90064 D 1 primary_doc.xml X0708 D LIVE 0001873835 Immix Biopharma, Inc. 11400 W OLYMPIC BLVD SUITE 200 LOS ANGELES CA CALIFORNIA 90064 (310) 651-8041 DELAWARE None None Corporation true Ilya Rachman c/o 11400 W OLYMPIC BLVD SUITE 200 LOS ANGELES CA CALIFORNIA 90064 Executive Officer Director Chief Executive Officer, Director Gabriel Morris c/o 11400 W OLYMPIC BLVD SUITE 200 LOS ANGELES CA CALIFORNIA 90064 Executive Officer Director Chief Financial Officer, Director Yekaterina Chudnovsky c/o 11400 W OLYMPIC BLVD SUITE 200 LOS ANGELES CA CALIFORNIA 90064 Director Director Jason Hsu c/o 11400 W OLYMPIC BLVD SUITE 200 LOS ANGELES CA CALIFORNIA 90064 Director Director Magda Marquet c/o 11400 W OLYMPIC BLVD SUITE 200 LOS ANGELES CA CALIFORNIA 90064 Director Director Jane Buchan c/o 11400 W OLYMPIC BLVD SUITE 200 LOS ANGELES CA CALIFORNIA 90064 Director Director Helen C. Adams c/o 11400 W OLYMPIC BLVD SUITE 200 LOS ANGELES CA CALIFORNIA 90064 Director Director Carey Ng c/o 11400 W OLYMPIC BLVD SUITE 200 LOS ANGELES CA CALIFORNIA 90064 Director Director Biotechnology Decline to Disclose 06b false 2024-05-20 false true true Acquisition of minority interest not already owned by Immix Biopharma, Inc. in subsidiary Nexcella, Inc. via short form merger 0 None None None None None None None XX Unknown NA CA CALIFORNIA FL FLORIDA NY NEW YORK false Indefinite 0 Indefinite This Form D relates to the Issuer's issuance of shares of its common stock in connection with the acquisition of the minority interest not already owned by the Issuer in its greater than 95% owned subsidiary, Nexcella, Inc., via short form merger false 14 0 0 0 Other than the payment of salaries and other compensation and benefits, no officer, director or promoter will receive any payments from the proceeds of this offering. false Immix Biopharma, Inc. /s/ Ilya Rachman Ilya Rachman Chief Executive Officer 2024-05-20